Scarica l'app Stockscreener
240.96
0.63%
1.50
Dopo l'orario di chiusura:
240.96
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché DVA Giù?
Forum
Previsione
Frazionamento azionario
Davita Inc Borsa (DVA) Ultime notizie
DaVita Healthcare Partners stock hits all-time high at 239.72 USD - Investing.com Canada
DaVita Inc (DVA) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
DaVita Inc (DVA) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
DaVita Inc (DVA) Income Statement - TradingKey
DaVita Inc (DVA) Institutional Confidence - TradingKey
DVA|DaVita Inc|Price:236.300|Chg%:+0.860 - TradingKey
DaVita stock trades steadily as dialysis volumes support margins - Ad-hoc-news.de
DVA|DaVita Inc|Price:235.440|Chg%:+1.160 - TradingKey
DaVita Inc. Revenue Breakdown – NYSE:DVA - TradingView
DaVita stock holds steady after recent earnings context - AD HOC NEWS
Davita: Valuation Is Nearing Resistance Level (NYSE:DVA) - Seeking Alpha
DaVita stock trades steadily as recent quarterly earnings highlight stable dialysis demand - AD HOC NEWS
DaVita Company Profile & Introduction - Moomoo
DaVita Inc. (DVA) Stock Forecasts - Yahoo! Finance Canada
Moon Capital Management Exited DaVita (DVA) with 174% total Return - Yahoo Finance
DaVita stock trades steadily as dialysis volumes support revenue growth - Ad-hoc-news.de
DaVita Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Summer Heat, Hydration and ESKD: Mitigating Health Risks - DaVita Newsroom
DaVita stock holds on dialysis revenue and margin trends - AD HOC NEWS
DaVita Inc. to announce Q2FY26 results on August 4 - scanx.trade
DaVita schedules Q2 earnings call for August 4, 2026, after market close. - Pluang
DaVita Inc. stock underperforms Tuesday when compared to competitors despite daily gains - MarketWatch
DaVita Inc. Schedules 2nd Quarter 2026 Investor Conference Call - KITV
What you need to know ahead of DaVita’s earnings release - MSN
DaVita stock trades steady as dialysis operator highlights cash flow and growth investments - AD HOC NEWS
DaVita stock holds firm as earnings and cash flow support dialysis strategy - Ad-hoc-news.de
DaVita stock benefits from expanding community-based kidney care - MSN
DaVita stock trades steadily as dialysis margins and leverage stay in focus - Ad-hoc-news.de
DaVita stock trades steady as chronic kidney care demand supports earnings trajectory - Ad-hoc-news.de
DaVita HealthCare (DVA) Advances While Market Declines: Some Information for Investors - Yahoo Finance
DaVita Inc. stock outperforms competitors on strong trading day - MarketWatch
DaVita Wins Bid To Decertify 1,300-Member Collective - Law360
DaVita: Why We Exited Our Position In Q2 (DVA) - Seeking Alpha
DaVita gains 21.4% in three months: How should you play the stock? - MSN
DaVita stock trades steadily as kidney care margins and cash flow support valuation - Ad-hoc-news.de
DaVita HealthCare (DVA) Rises As Market Takes a Dip: Key Facts - Yahoo Finance
DaVita Inc. stock underperforms Thursday when compared to competitors despite daily gains - MarketWatch
DaVita shares more than double after strong Q1 and court win; analyst sells most shares, rates Hold. - Pluang
DaVita: I Believe This Is Overvalued (NYSE:DVA) - Seeking Alpha
What You Need To Know Ahead of DaVita’s Earnings Release - Yahoo Finance
DaVita Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Truist Raises Price Target on DaVita to $250 From $205, Keeps Hold Rating - Moomoo
Truist Financial Maintains DaVita(DVA.US) With Hold Rating, Raises Target Price to $250 - Moomoo
DaVita expands comprehensive kidney care through dialysis services - MSN
DaVita stock holds steady as kidney care specialist focuses on operations and long-term dialysis dem - ad-hoc-news.de
DaVita Inc. (DVA) Stock Analysis: Strong ROE And Growth Potential In Healthcare Sector - DirectorsTalk Interviews
Exciting News for Farmington: DaVita Maple Valley is Expandi... - Park Hills Daily Journal
DaVita stock reflects steady dialysis demand amid US healthcare focus - ad-hoc-news.de
DVA stock holds steady as dialysis demand underpins the long-term case - ad-hoc-news.de
DaVita HealthCare (DVA) Laps the Stock Market: Here's Why - Yahoo Finance
DaVita Can Return to Long-Term Volume Growth of 2% by 2029, UBS Says - Moomoo
DaVita stock holds steady as kidney care demand supports long term outlook - ad-hoc-news.de
UBS Adjusts Price Target on DaVita to $270 From $235 - marketscreener.com
Everyone Is Watching Greg Abel. But Another Berkshire Hathaway Stock Picker Is Quietly Winning in 2026. - The Motley Fool
DAVITA INC. : BARCLAYS RAISES TARGET PRICE TO $218 FROM $194 - Moomoo
DaVita Inc focus on kidney care operations as investors watch US healthcare demand - Ad-hoc-news.de
DaVita HealthCare (DVA) Suffers a Larger Drop Than the General Market: Key Insights - Yahoo Finance
DaVita stock benefits from strengthening kidney care delivery - MSN
0.44%
1.92%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):